Abarca Health Launches AI Software Darwin H/I
The new system aims to streamline prescription drug management and coverage reviews for millions of members.
Updated on Oct. 26, 2026 in Healthcare
Live Poll
Do you trust artificial intelligence to handle medical coverage and authorization decisions for patients?
Abarca Health has officially launched Darwin H/I, an AI-powered software update designed to optimize pharmacy benefit operations. The platform integrates new tools to assist with administrative tasks and clinical coverage determinations.
Why it matters
By connecting operational data and automating routine reviews, the system seeks to reduce administrative burdens for providers and health plans. This launch marks a significant integration of technology into the company's management of large-scale drug spending.
Abarca Health currently manages $14 billion in annual prescription drug spending for its network. The combined company now serves over 9 million members, an increase from the 7.5 million people Abarca served earlier this year.
The players
Abarca Health
Based in Puerto Rico, this organization operates as a pharmacy benefit manager that handles prescription drug programs.
LucyRx
This company provides pharmacy benefit management services and recently completed a merger with Abarca Health.
The details
The Darwin H/I system features three core components: Darwin Context, Charlie, and Darwin PAth, which assists with prior authorization processes. While the software provides decision support, clinicians retain final authority over all coverage determinations.
Timeline
June 2026: Abarca and LucyRx announced their combination transaction.
August 20, 2026: The companies completed their business combination.
October 26, 2026: Abarca Health launched the Darwin H/I system.
Market Landscape
The launch of Darwin H/I aligns with the industry-wide mandate under the CMS Prior Authorization Final Rule to increase transparency and speed in coverage decisions. By combining with LucyRx, Abarca Health is positioning itself to compete more aggressively in a market that is increasingly prioritizing automated, data-driven administrative efficiency.
Members managed under these health plans may experience faster prior authorization turnaround times as providers utilize the new software tools. This integration aims to minimize administrative delays in receiving necessary prescription drug coverage.
The takeaway
The integration of AI into pharmacy benefit management represents a broader industry shift toward reducing human-intensive administrative work. Providers and patients should expect automated systems to become the standard for navigating complex insurance coverage requirements.
Further reading
For more information on the evolving sector, visit the United States Healthcare section.
Source note: This article includes information reported by News is My Business.
Live Poll
Do you trust artificial intelligence to handle medical coverage and authorization decisions for patients?
